| |
T/T
|
T/C
|
C/C
|
T/T vs. T/C vs. C/C
|
T/T vs. T/C + C/C
|
T/T + T/C vs. C/C
|
|---|
| |
N= 34
|
N= 37
|
N= 7
|
(ANOVA)
|
t test
|
t test
|
|---|
|
Urine specific gravity
|
1,012 ± 0.007
|
1,013 ± 0.007
|
1,019 ± 0.008
|
p = 0.052
|
p = 0.215
|
p = 0.035
|
|
Serum creatinine, total (mg/dl)
|
0.89 ± 0.20
|
0.99 ± 0.28
|
0.98 ± 0.23
|
p = 0.448
|
p = 0.074
|
p = 0.603
|
|
Male
|
1.19 ± 0.25
|
1.16 ± 0.32
|
1.22 ± 0.10
|
p = 0.939
|
p = 0.884
|
p = 0.781
|
|
N = 6
|
N = 16
|
N = 3
|
|
Female
|
0.83 ± 0.12
|
0.85 ± 0.14
|
0.80 ± 0.06
|
p = 0.774
|
p = 0.772
|
p = 0.515
|
|
N = 28
|
N = 21
|
N = 4
|
|
Estimated glomerular filtration rate (ml/min/1.73 m2)
|
71 ± 13
|
71 ± 16
|
68 ± 9
|
p = 0.977
|
p = 1.000
|
p = 0.606
|
|
Serum neutrophil gelatinase-associated lipocalin (ng/ml)
|
288 ± 89
|
321 ± 142
|
248 ± 81
|
p = 0.441
|
p = 0436
|
p = 0.216
|
|
Urine beta2-microglobulin (μg/ml)
|
0.22 ± 0.24
|
0.16 ± 0.14
|
0.13 ± 0.05
|
p = 0.279
|
p = 0.162
|
p = 0.410
|
- The p values of the differences in kidney function values are expressed as means ± SD. Italicized p value indicates urine specific gravity significantly higher in C/C patients compared to remaining genotypes combined.
